Download Drug Interactions in Infectious Diseases by V.S. Georgiev PDF

By V.S. Georgiev

ToC:

Section 1. basic Concepts

1. advent to Drug Interactions

2. Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion

3. Mechanisms of Drug Interactions II: shipping Proteins

4. Drug-Food Interactions

Section 2: Drug Classes

1. Antiretrovirals

2. Non-HIV Antivirals

3. Rifamycins and different Anti-Tubercular Agents

4. Macrolides, Azolides, and Ketolides

5. Quinolones

6. Beta-Lactam Antibiotics

7. Antifungal Agents

8. Antimalarial Agents

9. Antiprotozoal and Antithelmintic Agents

10. Glycopeptides and Lipopeptides

11. Tetracyclines, Aminoglycosides and Miscellaneous Antibiotics

11. Drug-Cytokine Interactions

12. Drug Interactions with Herbal/Alternative Medicines

Section three: study Issues

1. Drug Interactions: Regulatory standpoint

2. Probe Cocktail Studies

3. layout and information research of Drug interplay Studies

Show description

Read Online or Download Drug Interactions in Infectious Diseases PDF

Similar infectious diseases books

Current Topics in Complement II

Aegean meetings is an self sufficient, nonprofit, academic association directed and controlled by means of the medical neighborhood. The board is made from 9 researchers/scientists in quite a few disciplines from Harvard, Brown, collage of Pennsylvania, UCSD, Princeton, Biovista and the root for Biomedical learn Academy of Athens.

Der Experimentator: Immunologie

Lieber EXPERIMENTATOR,seit der Erstauflage im Jahr 2004 ist nun die four. Auflage des Immuno-EXPERIMENTATORS erschienen. Das Werk präsentiert die methodische Vielfalt der Immunologie, indem es die gängigen Methoden auf einfache Weise erklärt und auf Vor- und Nachteile sowie auf kritische Punkte eingeht.

Additional info for Drug Interactions in Infectious Diseases

Sample text

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin Pharmacol Ther 1998;64:123–128. 74. Cormet-Boyaka E, Huneau JF, Mordrelle A, et al. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother 1998;42:2607–2611. 75. Annaert P, Van Gelder J, Naesens L, et al. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.

Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 1997;32:210–258. 49. Bonkovsky HL, Hauri HP, Marti U, et al. Cytochrome P450 of small intestinal epithelial cells. Gastroenterology 1985;88:458–467. 50. Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994;26:144–160. 51. Paine MF, Khalighi M, Fisher JM, et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

J Biol Chem 1995;270:25,233–25,238. 121. Morgan ET, Thomas KB, Swanson R, et al. Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim Biophys Acta 1994;1219: 475–483. 122. Wright K, Morgan ET. Regulation of cytochrome P450IIC12 expression by interleukin1 α, interleukin-6, and dexamethasone. Mol Pharmacol 1991;39:468–474. 123. Abdel-Razzak Z, Corcos L, Fautrel A, et al. Interleukin-1 β antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture.

Download PDF sample

Rated 4.62 of 5 – based on 12 votes